A NOVEL SENOLYTIC NANOFORMULATION TARGETING THE HEPATIC SINUSOID IMPROVES HEPATIC FUNCTION AND FIBROSIS IN EXPERIMENTAL MODELS OF AGING

被引：0
|
作者：
Sanfeliu-Redondo, David [1 ]
Francisco, Vitor [2 ]
Tome, Ines [2 ,3 ]
Marques, Andreia [2 ,4 ]
Aristu, Peio [1 ,5 ]
Pitrez, Joao [2 ,6 ]
Rosa, Susana [2 ]
Ferreira, Lino [2 ,4 ]
Gracia-Sancho, Jordi [1 ,7 ]
机构：
[1] Hosp Clin Barcelona, Idibaps, Ciberehd, Barcelona, Spain
[2] Univ Coimbra, Cnc Ctr Neurosci & Cell Biol, Coimbra, Portugal
[3] Univ Coimbra, Fac Pharm, Coimbra, Portugal
[4] Univ Coimbra, Fac Med, Coimbra, Portugal
[5] BLB, Barcelona, Spain
[6] Inst Super Engn Coimbra, Coimbra, Portugal
[7] Univ Bern, Inselspital, Bern, Switzerland
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2614-A
引用
收藏
页码：S1256 / S1257
页数：2
相关论文
共 50 条
  • [31] A Novel Small Compound That Promotes Nuclear Translocation of YB-1 Ameliorates Experimental Hepatic Fibrosis in Mice
    Higashi, Kiyoshi
    Tomigahara, Yoshitaka
    Shiraki, Hiroaki
    Miyata, Kaori
    Mikami, Toshiyuki
    Kimura, Toru
    Moro, Tadashi
    Inagaki, Yutaka
    Kaneko, Hideo
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (06) : 4485 - 4492
  • [32] A novel small compound that promotes nuclear translocation of YB-1 suppresses experimental hepatic fibrosis in mice
    Masuda, Takahiro
    Tsuda, Makoto
    Yoshinaga, Ryohei
    Tamura, Tomohiko
    Inoue, Kazuhide
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 115P - 115P
  • [33] A novel small compound that promotes nuclear translocation of YB-1 suppresses experimental hepatic fibrosis in mice
    Higashi, Kiyoshi
    Tomigahara, Yoshitaka
    Shiraki, Hiroaki
    Nishioka, Kazuhiko
    Miyata, Kaori
    Mikami, Toshiyuki
    Kimura, Toru
    Inagaki, Yutaka
    Kaneko, Hideo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 115P - 115P
  • [34] Targeting A-kinase anchoring protein 12 phosphorylation in hepatic stellate cells regulates liver injury and fibrosis in mouse models
    Ramani, Komal
    Mavila, Nirmala
    Abeynayake, Aushinie
    Tomasi, Maria Lauda
    Wang, Jiaohong
    Matsuda, Michitaka
    Seki, Eki
    Mani, Arya
    ELIFE, 2022, 11
  • [35] Novel oral plasminogen activator inhibitor-1 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rat NASH models.
    Noguchi, Ryuichi
    Kaji, Kosuke
    Namisaki, Tadashi
    Moriya, Kei
    Kitade, Mitsuteru
    Nishimura, Norihisa
    Yoshiji, Hitoshi
    HEPATOLOGY, 2017, 66 : 223A - 224A
  • [36] A novel FXR agonist EDP-305 potently suppresses hepatic stellate cell activation and hepatic fibrosis in chronic mouse models of biliary and metabolic liver disease
    An, Ping
    Vaid, Kahini A.
    Wei, Guangyan
    Lin, Yi
    Chau, Mary D.
    Li, Yang
    Or, Yat Sun
    Jiang, Li-Juan
    Popov, Yury
    HEPATOLOGY, 2017, 66 : 206A - 206A
  • [37] A Novel GPR119 Agonist, DA-1241, Improves Hepatic Inflammation and Fibrosis in ob-NASH Mice
    Park, Hansu
    Lee, Boram
    Chae, Yuna
    Kim, Mi-Kyung
    DIABETES, 2020, 69
  • [38] Novel Rho associated coiled kinase inhibitor improves hepatic fibrosis in mice model of non-alcoholic steatohepatitis (NASH)
    Ali, Quaisar
    Prakash, Natalia
    Dalapati, Sony
    Li, Jingsong
    Goldberg, Itzhak
    Paka, Latha
    JOURNAL OF HEPATOLOGY, 2020, 73 : S524 - S524
  • [39] A Novel Nanoscale Phase-Change Contrast Agent Evaluates the Hepatic Fibrosis Through Targeting Hepatic Stellate Cell Platelet-Derived Factor Beta Receptor by Ultrasound in Vitro
    Li, Han-mei
    Feng, Lin-li
    Jiang, Qiong
    Yang, You
    Zhang, Ju-ying
    Luo, Xia
    Yang, Xing
    Ren, Bo
    Ye, Li-tao
    Hou, Zheng-ju
    Li, Yang
    Yu, Jin-hong
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2025, 51 (03): : 508 - 518
  • [40] Novel oral SPT inhibitor CH5169356 inhibits hepatic stellate cell activation and ameliorates hepatic fibrosis in mouse models of non-alcoholic steatohepatitis (NASH)
    Hada, Natsuko
    Katsume, Asao
    Kenichi, Kawasaki
    Endo, Chihiro
    Horiba, Naoshi
    Sudoh, Masayuki
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2023, 11 (03): : e01094
12345